1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care & Rapid Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Rapid Test
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Point of Care & Rapid Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care & Rapid Diagnostics Market Perspective (2018-2029)
2.2 Point of Care & Rapid Diagnostics Growth Trends by Region
2.2.1 Global Point of Care & Rapid Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Point of Care & Rapid Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Point of Care & Rapid Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Point of Care & Rapid Diagnostics Market Dynamics
2.3.1 Point of Care & Rapid Diagnostics Industry Trends
2.3.2 Point of Care & Rapid Diagnostics Market Drivers
2.3.3 Point of Care & Rapid Diagnostics Market Challenges
2.3.4 Point of Care & Rapid Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue
3.1.1 Global Top Point of Care & Rapid Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Point of Care & Rapid Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Point of Care & Rapid Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Point of Care & Rapid Diagnostics Revenue
3.4 Global Point of Care & Rapid Diagnostics Market Concentration Ratio
3.4.1 Global Point of Care & Rapid Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care & Rapid Diagnostics Revenue in 2022
3.5 Point of Care & Rapid Diagnostics Key Players Head office and Area Served
3.6 Key Players Point of Care & Rapid Diagnostics Product Solution and Service
3.7 Date of Enter into Point of Care & Rapid Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care & Rapid Diagnostics Breakdown Data by Type
4.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Type (2024-2029)
5 Point of Care & Rapid Diagnostics Breakdown Data by Application
5.1 Global Point of Care & Rapid Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Point of Care & Rapid Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Point of Care & Rapid Diagnostics Market Size (2018-2029)
6.2 North America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
6.4 North America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care & Rapid Diagnostics Market Size (2018-2029)
7.2 Europe Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
7.4 Europe Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care & Rapid Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Point of Care & Rapid Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Point of Care & Rapid Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care & Rapid Diagnostics Market Size (2018-2029)
9.2 Latin America Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care & Rapid Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Point of Care & Rapid Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Point of Care & Rapid Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Point of Care & Rapid Diagnostics Introduction
11.1.4 Johnson and Johnson Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Point of Care & Rapid Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Point of Care & Rapid Diagnostics Introduction
11.3.4 Bio-Techne Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.3.5 Bio-Techne Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Point of Care & Rapid Diagnostics Introduction
11.4.4 Roche Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.4.5 Roche Diagnostics Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Point of Care & Rapid Diagnostics Introduction
11.5.4 Siemens Healthineers Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Detail
11.6.2 Abbott Laboratories Business Overview
11.6.3 Abbott Laboratories Point of Care & Rapid Diagnostics Introduction
11.6.4 Abbott Laboratories Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.6.5 Abbott Laboratories Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Detail
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Point of Care & Rapid Diagnostics Introduction
11.7.4 Danaher Corporation Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.7.5 Danaher Corporation Recent Development
11.8 BD
11.8.1 BD Company Detail
11.8.2 BD Business Overview
11.8.3 BD Point of Care & Rapid Diagnostics Introduction
11.8.4 BD Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.8.5 BD Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex Point of Care & Rapid Diagnostics Introduction
11.9.4 Sysmex Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.9.5 Sysmex Recent Development
11.10 Cardinal Health
11.10.1 Cardinal Health Company Detail
11.10.2 Cardinal Health Business Overview
11.10.3 Cardinal Health Point of Care & Rapid Diagnostics Introduction
11.10.4 Cardinal Health Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.10.5 Cardinal Health Recent Development
11.11 Quidel
11.11.1 Quidel Company Detail
11.11.2 Quidel Business Overview
11.11.3 Quidel Point of Care & Rapid Diagnostics Introduction
11.11.4 Quidel Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.11.5 Quidel Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Detail
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare Point of Care & Rapid Diagnostics Introduction
11.12.4 GE Healthcare Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.12.5 GE Healthcare Recent Development
11.13 EKF Diagnostics
11.13.1 EKF Diagnostics Company Detail
11.13.2 EKF Diagnostics Business Overview
11.13.3 EKF Diagnostics Point of Care & Rapid Diagnostics Introduction
11.13.4 EKF Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.13.5 EKF Diagnostics Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Detail
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Point of Care & Rapid Diagnostics Introduction
11.14.4 bioMérieux SA Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.14.5 bioMérieux SA Recent Development
11.15 Accubiotech
11.15.1 Accubiotech Company Detail
11.15.2 Accubiotech Business Overview
11.15.3 Accubiotech Point of Care & Rapid Diagnostics Introduction
11.15.4 Accubiotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.15.5 Accubiotech Recent Development
11.16 PTS Diagnostics
11.16.1 PTS Diagnostics Company Detail
11.16.2 PTS Diagnostics Business Overview
11.16.3 PTS Diagnostics Point of Care & Rapid Diagnostics Introduction
11.16.4 PTS Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.16.5 PTS Diagnostics Recent Development
11.17 Chembio Diagnostics
11.17.1 Chembio Diagnostics Company Detail
11.17.2 Chembio Diagnostics Business Overview
11.17.3 Chembio Diagnostics Point of Care & Rapid Diagnostics Introduction
11.17.4 Chembio Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.17.5 Chembio Diagnostics Recent Development
11.18 Trinity Biotech
11.18.1 Trinity Biotech Company Detail
11.18.2 Trinity Biotech Business Overview
11.18.3 Trinity Biotech Point of Care & Rapid Diagnostics Introduction
11.18.4 Trinity Biotech Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.18.5 Trinity Biotech Recent Development
11.19 Sekisui Diagnostics
11.19.1 Sekisui Diagnostics Company Detail
11.19.2 Sekisui Diagnostics Business Overview
11.19.3 Sekisui Diagnostics Point of Care & Rapid Diagnostics Introduction
11.19.4 Sekisui Diagnostics Revenue in Point of Care & Rapid Diagnostics Business (2018-2023)
11.19.5 Sekisui Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| ※参考情報 ポイントオブケア（POC）および迅速診断は、医療現場において非常に重要な概念です。これらは、患者に対して迅速かつ効率的に診断を行う方法として広く利用されており、特に緊急性が求められる状況や、資源が限られた環境での使用が顕著です。以下に、POCおよび迅速診断の定義、特徴、種類、用途、関連技術について詳しく説明いたします。 ポイントオブケア（POC）診断は、医療提供者が患者のそばで、もしくはその近くで行える診断手法のことを指します。この手法は、従来のラボでの検査と比較して、結果が迅速に得られるため、即時の治療や介入を可能にします。従来の診断手法は、多くの場合、試料を収集し、ラボに送付して結果を待つ必要があり、その過程には数時間から数日がかかることもあります。このため、POC診断は、特に緊急医療や一次医療において重要な役割を果たします。 POC診断の特徴として、まず「迅速性」が挙げられます。患者の確認や治療を迅速に行えることは、治療成績の向上や合併症の予防につながります。また、POC診断は「操作の簡便さ」という特徴も持っています。一般的に、あまり高度な専門知識がなくても操作できるように設計されており、医療従事者の負担を軽減します。さらに、これらの診断は多くの場合、ポータブルであり、移動が可能なため、さまざまな場面で適用できます。 POC診断の種類は多岐にわたります。代表的なものには、血糖モニタリング、感染症の迅速診断、バイタルサインモニタリング、妊娠検査、腫瘍マーカーの測定などがあります。これらはすべて、患者の診断や治療の意思決定に迅速に寄与するため、POC診断の重要な例です。 感染症の迅速診断は、POC診断において特に注目されている領域です。インフルエンザウイルス、COVID-19、A群β溶血性連鎖球菌などが迅速に検出できるテストは、適切な治療を迅速に開始するために必要不可欠です。これにより、感染症の流行を抑制し、公共の健康を守ることができるのです。 用途については、POC診断は多くの医療現場で広く使用されております。特に、救急医療、地域医療、遠隔地の医療施設、発展途上国の診療所など、さまざまな環境で活用されています。救急医療では、即時の判断を要するケースが多く、POC診断が患者の生死を分けることもあります。さらに、地域医療では、慢性疾患のモニタリングや予防医療にも役立ちます。 関連技術としては、POC診断は新しいテクノロジーによって進化を続けています。例えば、バイオセンサー技術、ラピッドアッセイ技術、ナノテクノロジーなどがこれに該当します。バイオセンサーは生体物質を検出するために設計されたセンサーであり、高い感度と特異性を持つため、POC診断において非常に有用です。ラピッドアッセイ技術は、短時間で結果を得ることを可能にし、特に感染症の検出や、腫瘍マーカーの測定でよく用いられています。ナノテクノロジーは、微細な材料を利用して感度を向上させることが可能であり、POC診断の精度を向上させる新たなアプローチとなっています。 また、近年ではデジタルヘルスやテレメディスンの進展とも相まって、POC診断がより広範に使用されるようになっています。モバイルアプリやクラウドサービスを通じたデータの収集および管理が進み、診断結果をリアルタイムで専門家に送信し、適切なアドバイスを得ることが可能になっています。これにより、患者と医療従事者の連携が強化され、より効果的な治療が実現されます。 総じて、ポイントオブケアおよび迅速診断は、医療の質を向上させるための重要な手段です。患者の即時のニーズに応えられる技術として、特に迅速性や操作性、携帯性に優れていることが特長です。また、多様な用途や関連技術がそれを支え、今後の医療現場でのさらなる発展が期待されています。このような診断手法の普及は、医療アクセスの向上や、患者の治療成績の向上につながることでしょう。今後も、POC診断および迅速診断の技術革新が続くことにより、さらに多くの患者がその恩恵を受けることが期待されます。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
